Literature DB >> 2859190

Somatostatin receptors in the rat adrenal cortex: characterization and comparison with brain and pituitary receptors.

C B Srikant, Y C Patel.   

Abstract

Specific receptors for tetradecapeptide somatostatin (S-14) in rat adrenal cortical membranes were quantitated by direct binding studies using [125I-Tyr11]S-14. Competitive inhibition of this radioligand by S-14 showed that these receptors constitute a single class of high affinity binding sites [dissociation constant (Kd) = 1.08 nM and maximum binding capacity (Bmax) = 0.35 pmol/mg membrane protein]. Structural analogs of S-14 with halogenated Trp8 moiety exhibited 4- to 46-fold greater binding affinity than S-14, [D-F5-Trp8]S-14 being the most potent. [Tyr11]S-14 and [des-Ala1]S-14 bound to these receptors with reduced affinity whereas [Phe4]S-14 exhibited 1.5-fold greater affinity than S-14. Somatostatin-28 (S-28) and S-14 were equipotent, whereas the N-terminal fragments of S-28 [S-28(1-14) and S-28(1-12)] were inactive. High affinity binding sites were also quantitated using a radioligand prepared from the tyrosinated S-28 analog, [Leu8, D-Trp22, Tyr25]S-28 (Kd = 1.2 nM; Bmax = 0.21 pmol/mg membrane protein). Both S-14 and S-28 exhibited comparable relative potencies for inhibiting the specific binding of this radioligand and [125I-Tyr11]S-14. Extracts of whole adrenal or the adrenal medulla and cortex contained very low levels of S-14-like immunoreactivity (2.4 pg/mg protein). These studies confirm the presence of specific receptors for S-14 in the adrenal cortex and suggest that 1) with respect to S-14 biological activity, Trp8-modified S-14 analogs should be more potent than S-14, S-28 equipotent with S-14, and N-terminal fragments of S-28 inactive in this tissue. 2) Direct binding studies using radioiodinated [Tyr11]S-14 and [Leu8,D-Trp22, Tyr25]S-28 appear to quantitate the same receptor sites in adrenocortical tissue. 3) The ligand specificity of the adrenocortical S-14 receptor differs from that previously reported for the pituitary and brain providing further evidence for the heterogeneity of the S-14 receptor. 4) In view of the very low concentrations of endogenous S-14-like immunoreactivity, the adrenal actions of S-14 and S-28 are probably mediated through an endocrine mechanism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2859190     DOI: 10.1210/endo-116-5-1717

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Tissue-specific distribution of cross-linked somatostatin receptor proteins in the rat.

Authors:  C B Srikant; K K Murthy; Y C Patel
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

2.  Somatostatin receptors on human lymphocytes and leukaemia cells.

Authors:  K Hiruma; T Koike; H Nakamura; T Sumida; T Maeda; H Tomioka; S Yoshida; T Fujita
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

3.  Identification of lymphoid cell lines bearing receptors for somatostatin.

Authors:  H Nakamura; T Koike; K Hiruma; T Sato; H Tomioka; S Yoshida
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

Review 4.  Somatostatin.

Authors:  S R Bloom; J M Polak
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-01

5.  Effect of somatostatin analog (SMS 201-995) on in vivo intestinal fluid transport in rats. A limited systemic effect.

Authors:  R N Fedorak; S L Allen
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

6.  Somatostatin immunoreactivity in the cat adrenal medulla. Localization and characterization.

Authors:  S R Vincent; C H McIntosh; P B Reiner; J C Brown
Journal:  Histochemistry       Date:  1987

7.  Ultrastructural distribution of somatostatin-14 and -28 in rat adrenal cells.

Authors:  G Morel; P Leroux; T Garcia Caballero; A Beiras; F Gossard
Journal:  Cell Tissue Res       Date:  1990-09       Impact factor: 5.249

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.